<p>(A) (B) NVP-BEZ235 blocked the phosphorylation of AKT, GSK3β, PRAS40, mTOR, S6K and 4E-BP1 in CNE2 and HONE1 cells. Cells were cultured at 2∼4×10<sup>5</sup>cells/well in 6-well plates and were treated with NVP-BEZ235 0.25 µM in indicated periods and different concentrations for 6 h and analyzed by Western blotting.</p
Mantle cell lymphoma (MCL) is a distinct subtype of B-cell lymphoma; the complete response rate for ...
Mantle cell lymphoma (MCL) is a distinct subtype of B-cell lymphoma; the complete response rate for ...
<p>(A) (B) Combination of CDDP and NVP-BEZ235 synergistically inhibited cell proliferation. Cells we...
<p>(A) CDDP increased the phosphorylation of downstream substrates of PI3K/AKT and mTORC1 pathways. ...
<p>(A) Cell viability of mutant and wild-type isogenic <i>PIK3CA</i> cells was assessed by MTS assay...
<p>(A) Inhibitory effects of NVP-BEZ235 on NPC cells and normal nasopharyngeal cells. Cells were cul...
<p><b>A</b> Cells were either left untreated, treated for 24 µM PI-103, a well-characterized pan-PI3...
<p>(A) NVP-BEZ235 increased G1 phase cells population. Cells were cultured at the density of 0.5∼1×1...
<p>(A) (B) The antitumor efficacies of NVP-BEZ235, CDDP and combination of NVP-BEZ235and CDDP in CNE...
Phosphatidylinositol-3-kinase (PI3K) pathway deregulation is a common event in human cancer, either ...
<p>A: HMC-1.1 cells (upper panel), HMC-1.2 cells (middle panel), and KU812 cells (lower panel) were ...
Despite recent improvements in chemotherapy and surgery, the problem of non-response osteosarcoma to...
<p>p-AKT (Thr308) and p-AKT (Ser473) was increased in 8505C for more than 24 hours. p-AKT (Thr308) a...
The phosphatidylinositol-3-kinase (PI3K)/Akt signalling pathway is frequently deregulated in pancrea...
<p>A,B: HMC-1.1 cells (left panels), HMC-1.2 cells (middle panels), and KU812 cells (right panels) w...
Mantle cell lymphoma (MCL) is a distinct subtype of B-cell lymphoma; the complete response rate for ...
Mantle cell lymphoma (MCL) is a distinct subtype of B-cell lymphoma; the complete response rate for ...
<p>(A) (B) Combination of CDDP and NVP-BEZ235 synergistically inhibited cell proliferation. Cells we...
<p>(A) CDDP increased the phosphorylation of downstream substrates of PI3K/AKT and mTORC1 pathways. ...
<p>(A) Cell viability of mutant and wild-type isogenic <i>PIK3CA</i> cells was assessed by MTS assay...
<p>(A) Inhibitory effects of NVP-BEZ235 on NPC cells and normal nasopharyngeal cells. Cells were cul...
<p><b>A</b> Cells were either left untreated, treated for 24 µM PI-103, a well-characterized pan-PI3...
<p>(A) NVP-BEZ235 increased G1 phase cells population. Cells were cultured at the density of 0.5∼1×1...
<p>(A) (B) The antitumor efficacies of NVP-BEZ235, CDDP and combination of NVP-BEZ235and CDDP in CNE...
Phosphatidylinositol-3-kinase (PI3K) pathway deregulation is a common event in human cancer, either ...
<p>A: HMC-1.1 cells (upper panel), HMC-1.2 cells (middle panel), and KU812 cells (lower panel) were ...
Despite recent improvements in chemotherapy and surgery, the problem of non-response osteosarcoma to...
<p>p-AKT (Thr308) and p-AKT (Ser473) was increased in 8505C for more than 24 hours. p-AKT (Thr308) a...
The phosphatidylinositol-3-kinase (PI3K)/Akt signalling pathway is frequently deregulated in pancrea...
<p>A,B: HMC-1.1 cells (left panels), HMC-1.2 cells (middle panels), and KU812 cells (right panels) w...
Mantle cell lymphoma (MCL) is a distinct subtype of B-cell lymphoma; the complete response rate for ...
Mantle cell lymphoma (MCL) is a distinct subtype of B-cell lymphoma; the complete response rate for ...
<p>(A) (B) Combination of CDDP and NVP-BEZ235 synergistically inhibited cell proliferation. Cells we...